$CBIS The new laboratory can open the markets dra

$CBIS The new laboratory can open the markets dramatically for the Company's proprietary cannabinoid formulations being created to be distributed nationwide. The urgent objective is the treatment of critical ailments, such as various cancers, HIV/AIDS, pain management, autism, PTSD, and other neurological conditions. Though this list represents only a handful of the targeted ailments we hope to treat, it reflects some of the serious medical afflictions we are dealing with. The Company fully understands that while the price is high, one blockbuster pharmaceutical drug can change the framework forever in Cannabis Science, and the Company believes it has more than one.

https://finance.yahoo.com/news/cannabis-scien...42821.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!